KISS took Vancouver firm’s treatment to avoid COVID and cancelling world tour: manager

KISS band members used a little-known treatment created by a Vancouver biomedical company to avoid getting COVID, after lead singer Paul Stanley tested positive for the virus, and to avoid having to cancel the legendary band’s farewell world tour, their manager says.

“It would be impossible, not improbable, but impossible, for KISS to continue on its world tour without the protection of the Steriwave treatment,” manager Doc McGhee said in a press release.

Steriwave, created by Vancouver-based Ondine Biomedical, uses a light-activated disinfecting liquid to kill viruses in the nose, and is used by hospitals such as Vancouver General to reduce infections in surgery patients. Last Thursday, a study was released showing the use of this “nasal photodisinfection” at Ottawa Hospital reduced the length of patients’ hospital stays, readmissions and antibiotic use.

When the pandemic struck, a Toronto surgeon quietly began using Steriwave to see if it would also kill COVID, and prevent patients from contracting the virus. Results of a small medical study, released in January, found the treatment reduced COVID infections and lessened the progression of symptoms in those who had the virus.